• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Sellas Life Sciences released FY2025 9 Months Earnings on November 12 EST, with actual revenue of USD 0 and EPS of USD -0.1362
04:00
Sellas Life Sciences released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0626 (forecast USD -0.0766)
04:00
Aug13
Sellas Life Sciences released FY2025 Semi-Annual Earnings on August 12 (EST) with actual revenue of USD 0 and EPS of USD -0.1332
03:00
Sellas Life Sciences released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.07 (forecast USD -0.0766)
03:00
Jul15
SELLAS Life Sciences Group's SLS009 Phase 2 Trial Meets All Primary Endpoints in AML
11:46
Jul7
SELLAS Life Sciences Group Adds New Executive
13:52

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.791 M, EPS -0.0626

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.601 M, EPS -0.07

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.813 M, EPS -0.0662

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
20.080
+197.13%
+13.322
SMX
300.000
+112.77%
+159.000
WHLR
5.831
+79.98%
+2.530
GURE
8.051
+69.85%
+3.311
DBRG
14.505
+49.23%
+4.784
IRBT
4.310
+42.24%
+1.300
TORO
5.534
+33.98%
+1.404
LICN
3.859
+31.71%
+0.929
TDIC
0.3691
+31.45%
+0.088
PRAX
246.365
+29.69%
+56.395
View More